Food and Drug Regulation

Are Food Regulators Stepping up to the Plate?

Are Food Regulators Stepping up to the Plate?

In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.

Hallucinate, Medicate, and Regulate

Hallucinate, Medicate, and Regulate

In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.

Emergency Use or Overuse?

Emergency Use or Overuse?

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.

Hidden Racial Disparities in FDA-Required Research

Hidden Racial Disparities in FDA-Required Research

Current testing practices in the pharmaceutical industry exploit social and racial inequities.

Disclosing Gluten in Food

Disclosing Gluten in Food

Pending federal legislation would improve food information for consumers with gluten sensitivity.

Value-Pricing Prescription Drugs

Value-Pricing Prescription Drugs

Scholar argues that reducing pricing for prescription drugs may increase innovation.

Pet Food Regulations May Be More Bark Than Bite

Pet Food Regulations May Be More Bark Than Bite

Regulators strive to keep our animal companions’ food safe, but gaps remain.

Something Fishy About Seafood Inspection

Something Fishy About Seafood Inspection

Government watchdog finds that FDA is not properly inspecting imported seafood.

Making Drugs Safe to Kill?

Making Drugs Safe to Kill?

Lawyer proposes a new legal framework for reviewing FDA’s refusal to regulate lethal injection drugs.

Strengthening the Stem Cell Industry Through Better Regulation

Strengthening the Stem Cell Industry Through Better Regulation

FDA should take steps to strengthen the regenerative medicine industry.

Calls for Regulatory Approval of Edible Insects

Calls for Regulatory Approval of Edible Insects

Edible insects may become essential in the wake of the COVID-19 crisis, but FDA regulation is lacking.

Combatting Drug Shortages

Combatting Drug Shortages

A federal task force proposes regulatory solutions to mitigate drug shortages.